Advertisement

Retroperitoneal and Mesenteric Liposarcomas

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Porter G.A.
        • Baxter N.N.
        • Pisters P.W.
        Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy.
        Cancer Apr 1. 2006; 106: 1610-1616
        • Gatta G.
        • Capocaccia R.
        • Botta L.
        • et al.
        Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study.
        Lancet Oncol. 2017; 18: 1022-1039
      1. Soft tissue and bone tumours. WHO classification of tumours series; 5th edition, Vol. 3. International Agency for Research on Cancer (IARC); 2020.

        • Callegaro D.
        • Raut C.P.
        • Ng D.
        • et al.
        Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years.
        Ann Surg Oncol. 2021; 28: 1700-1709
        • Tattersall H.L.
        • Hodson J.
        • Cardona K.
        • et al.
        Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
        J Surg Oncol. 2021; 123: 1057-1066
        • Crago A.M.
        • Dickson M.A.
        Liposarcoma: Multimodality Management and Future Targeted Therapies.
        Surg Oncol Clin N Am. 2016; 25: 761-773
        • Mandahl N.
        • Akerman M.
        • Aman P.
        • et al.
        Duplication of chromosome segment 12q15-24 is associated with atypical lipomatous tumors: a report of the CHAMP collaborative study group. CHromosomes And MorPhology.
        Int J Cancer. 1996; 67: 632-635
        • Barretina J.
        • Taylor B.S.
        • Banerji S.
        • et al.
        Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.
        Nat Genet. 2010; 42: 715-721
        • Dalal K.M.
        • Kattan M.W.
        • Antonescu C.R.
        • et al.
        Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
        Ann Surg. 2006; 244: 381-391
        • Taguchi S.
        • Kume H.
        • Fukuhara H.
        • et al.
        Symptoms at diagnosis as independent prognostic factors in retroperitoneal liposarcoma.
        Mol Clin Oncol. 2016; 4: 255-260
        • Storm F.K.
        • Mahvi D.M.
        Diagnosis and management of retroperitoneal soft-tissue sarcoma.
        Ann Surg. 1991; 214: 2-10
        • Swallow C.J.
        • Strauss D.C.
        • Bonvalot S.
        • et al.
        Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.
        Ann Surg Oncol. 2021; 28: 7873-7888
        • Mv Mehren
        • Kane J.M.
        • Bui M.M.
        • et al.
        NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021: Featured Updates to the NCCN Guidelines.
        J Natl Compr Cancer Netw. 2020; 18: 1604-1612
        • Gronchi A.
        • Miah A.B.
        • Dei Tos A.P.
        • et al.
        • GENTURIS
        Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.
        Ann Oncol. 2021; 32: 1348-1365
        • Setsu N.
        • Miyake M.
        • Wakai S.
        • et al.
        Primary Retroperitoneal Myxoid Liposarcomas.
        Am J Surg Pathol. 2016; 40: 1286-1290
        • Moreau L.-C.
        • Turcotte R.
        • Ferguson P.
        • et al.
        Myxoid∖round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases.
        Ann Surg Oncol. 2012; 19: 1081-1088
        • Messiou C.
        • Morosi C.
        Imaging in retroperitoneal soft tissue sarcoma.
        J Surg Oncol. 2018; 117: 25-32
        • Messiou C.
        • Moskovic E.
        • Vanel D.
        • et al.
        Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm.
        Eur J Surg Oncol Jul. 2017; 43: 1191-1198
        • Fairweather M.
        • Wang J.
        • Jo V.Y.
        • et al.
        Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection.
        Ann Surg Oncol. 2018; 25: 98-106
        • Craig W.D.
        • Fanburg-Smith J.C.
        • Henry L.R.
        • et al.
        Fat-containing lesions of the retroperitoneum: radiologic-pathologic correlation.
        Radiographics. 2009; 29: 261-290
        • Subramaniam S.
        • Callahan J.
        • Bressel M.
        • et al.
        The role of 18F-FDG PET/CT in retroperitoneal sarcomas—A multicenter retrospective study.
        J Surg Oncol. 2021; 123: 1081-1087
        • Rhu J.
        • Hyun S.H.
        • Lee K.-H.
        • et al.
        Maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma.
        Scientific Rep. 2019; 9: 6605
        • Hain S.F.
        • O'Doherty M.J.
        • Bingham J.
        • et al.
        Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours?.
        Nucl Med Commun. 2003; 24: 1139-1143
        • Young R.
        • Snow H.
        • Hendry S.
        • et al.
        Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single-centre study.
        ANZ J Surg. 2020; 90: 497-502
        • Rakheja R.
        • Makis W.
        • Skamene S.
        • et al.
        Correlating Metabolic Activity on 18 F-FDG PET/CT With Histopathologic Characteristics of Osseous and Soft-Tissue Sarcomas: A Retrospective Review of 136 Patients.
        Am J Roentgenol. 2012; 198: 1409-1416
        • Parkes A.
        • Urquiola E.
        • Bhosale P.
        • et al.
        PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.
        Sarcoma. 2020; 2020: 8363986
        • Fairweather M.
        • Raut C.P.
        To Biopsy, or Not to Biopsy: Is There Really a Question?.
        Ann Surg Oncol. 2019; 26: 4182-4184
        • Strauss D.C.
        • Qureshi Y.A.
        • Hayes A.J.
        • et al.
        The role of core needle biopsy in the diagnosis of suspected soft tissue tumours.
        J Surg Oncol. 2010; 102: 523-529
        • van Houdt W.J.
        • Raut C.P.
        • Bonvalot S.
        • et al.
        New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration.
        Curr Opin Oncol. 2019; 31: 310-316
        • Berger-Richardson D.
        • Burtenshaw S.M.
        • Ibrahim A.M.
        • et al.
        Early and Late Complications of Percutaneous Core Needle Biopsy of Retroperitoneal Tumors at Two Tertiary Sarcoma Centers.
        Ann Surg Oncol. 2019; 26: 4692-4698
        • Van Houdt W.J.
        • Schrijver A.M.
        • Cohen-Hallaleh R.B.
        • et al.
        Needle tract seeding following core biopsies in retroperitoneal sarcoma.
        Eur J Surg Oncol. 2017; 43: 1740-1745
        • Weaver J.
        • Downs-Kelly E.
        • Goldblum J.R.
        • et al.
        Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
        Mod Pathol. 2008; 21: 943-949
        • Baranov E.
        • Black M.A.
        • Fletcher C.D.M.
        • et al.
        Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.
        Mod Pathol. 2021; 34: 1367-1372
        • Brennan M.F.
        • Antonescu C.R.
        • Moraco N.
        • et al.
        Lessons learned from the study of 10,000 patients with soft tissue sarcoma.
        Ann Surg. 2014; 260: 416-421
        • Bonvalot S.
        • Raut C.P.
        • Pollock R.E.
        • et al.
        Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG.
        Ann Surg Oncol. 2012; 19: 2981-2991
        • Singer S.
        • Antonescu C.R.
        • Riedel E.
        • et al.
        Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
        Ann Surg. 2003; 238: 358-370
        • Bonvalot S.
        • Rivoire M.
        • Castaing M.
        • et al.
        Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.
        J Clin Oncol. 2009; 27: 31-37
        • Gronchi A.
        • Lo Vullo S.
        • Fiore M.
        • et al.
        Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients.
        J Clin Oncol. 2009; 27: 24-30
        • Gronchi A.
        • Miceli R.
        • Colombo C.
        • et al.
        Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.
        Ann Oncol. 2012; 23: 1067-1073
        • Bonvalot S.
        • Miceli R.
        • Berselli M.
        • et al.
        Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control.
        Ann Surg Oncol. 2010; 17: 1507-1514
        • MacNeill A.J.
        • Gronchi A.
        • Miceli R.
        • et al.
        Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.
        Ann Surg. 2018; 267: 959-964
        • Gronchi A.
        • Pollock R.
        Surgery in retroperitoneal soft tissue sarcoma: a call for a consensus between Europe and North America.
        Ann Surg Oncol. 2011; 18: 2107-2110
        • Mussi C.
        • Colombo P.
        • Bertuzzi A.
        • et al.
        Retroperitoneal sarcoma: is it time to change the surgical policy?.
        Ann Surg Oncol. 2011; 18: 2136-2142
        • Ikoma N.
        • Roland C.L.
        • Torres K.E.
        • et al.
        Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center.
        J Surg Oncol. 2018; 117: 1188-1194
        • Strauss D.C.
        • Renne S.L.
        • Gronchi A.
        Adjacent, Adherent, Invaded: A Spectrum of Biologic Aggressiveness Rather Than a Rationale for Selecting Organ Resection in Surgery of Primary Retroperitoneal Sarcomas.
        Ann Surg Oncol. 2018; 25: 13-16
        • Keung E.Z.
        • Chiang Y.J.
        • Cormier J.N.
        • et al.
        Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
        Cancer. 2018; 124: 4495-4503
        • Villano A.M.
        • Zeymo A.
        • Chan K.S.
        • et al.
        Identifying the Minimum Volume Threshold for Retroperitoneal Soft Tissue Sarcoma Resection: Merging National Data with Consensus Expert Opinion.
        J Am Coll Surg. 2020; 230: 151-160 e2
        • Albertsmeier M.
        • Rauch A.
        • Roeder F.
        • et al.
        External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis.
        Ann Surg Oncol. 2018; 25: 754-767
        • Diamantis A.
        • Baloyiannis I.
        • Magouliotis D.E.
        • et al.
        Perioperative radiotherapy versus surgery alone for retroperitoneal sarcomas: a systematic review and meta-analysis.
        Radiol Oncol. 2020; 54: 14-21
        • Gronchi A.
        • Strauss D.C.
        • Miceli R.
        • et al.
        Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.
        Ann Surg. 2016; 263: 1002-1009
        • Haas R.L.M.
        • Bonvalot S.
        • Miceli R.
        • et al.
        Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.
        Cancer. 2019; 125: 1290-1300
        • Bates J.E.
        • Dhakal S.
        • Mazloom A.
        • et al.
        The Benefit of Adjuvant Radiotherapy in High-grade Nonmetastatic Retroperitoneal Soft Tissue Sarcoma: A SEER Analysis.
        Am J Clin Oncol. 2018; 41: 274-279
        • Baldini E.H.
        • Wang D.
        • Haas R.L.
        • et al.
        Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel.
        Int J Radiat Oncol Biol Phys. 2015; 92: 602-612
        • Pawlik T.M.
        • Ahuja N.
        • Herman J.M.
        The role of radiation in retroperitoneal sarcomas: a surgical perspective.
        Curr Opin Oncol. 2007; 19: 359-366
        • Jones J.J.
        • Catton C.N.
        • O'Sullivan B.
        • et al.
        Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma.
        Ann Surg Oncol. 2002; 9: 346-354
        • Krempien R.
        • Roeder F.
        • Oertel S.
        • et al.
        Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma.
        Int J Radiat Oncol Biol Phys. 2006; 65: 773-779
        • Bonvalot S.
        • Gronchi A.
        • Le Péchoux C.
        • et al.
        Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.
        Lancet Oncol. 2020; 21: 1366-1377
      2. Callegaro D, Gronchi A, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 trial (STRASS) vs off-trial (STREXIT) results. Annals of Surgery 2022;in press.

        • Almond L.M.
        • Gronchi A.
        • Strauss D.
        • et al.
        Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma.
        Eur J Surg Oncol. 2018; 44: 571-579
        • Livingston J.A.
        • Bugano D.
        • Barbo A.
        • et al.
        Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard.
        Scientific Rep. 2017; 7
        • Jones R.L.
        • Fisher C.
        • Al-Muderis O.
        • et al.
        Differential sensitivity of liposarcoma subtypes to chemotherapy.
        Eur J Cancer. 2005; 41: 2853-2860
        • Constantinidou A.
        • Jones R.L.
        Systemic therapy in retroperitoneal sarcoma management.
        J Surg Oncol. 2018; 117: 87-92
        • Tseng W.W.
        • Barretta F.
        • Conti L.
        • et al.
        Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.
        Cancer. 2021; 127: 729-738
      3. Surgery With Our Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma.
        • Gronchi A.
        • Collini P.
        • Miceli R.
        • et al.
        Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.
        Am J Surg Pathol. 2015; 39: 383-393
        • Tan M.C.
        • Brennan M.F.
        • Kuk D.
        • et al.
        Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.
        Ann Surg. 2016; 263: 593-600
        • Toulmonde M.
        • Bonvalot S.
        • Meeus P.
        • et al.
        Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
        Ann Oncol. 2014; 25: 735-742
        • Stoeckle E.
        • Coindre J.M.
        • Bonvalot S.
        • et al.
        Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group.
        Cancer. 2001; 92: 359-368
        • Anaya D.A.
        • Lahat G.
        • Liu J.
        • et al.
        Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making.
        Ann Surg. 2009; 249: 137-142
        • Anaya D.A.
        • Lev D.C.
        • Pollock R.E.
        The role of surgical margin status in retroperitoneal sarcoma.
        J Surg Oncol. 2008; 98: 607-610
        • Keung E.Z.
        • Hornick J.L.
        • Bertagnolli M.M.
        • et al.
        Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
        J Am Coll Surg. 2014; 218: 206-217
        • Kattan M.W.
        • Leung D.H.
        • Brennan M.F.
        Postoperative nomogram for 12-year sarcoma-specific death.
        J Clin Oncol. 2002; 20: 791-796
        • Anaya D.A.
        • Lahat G.
        • Wang X.
        • et al.
        Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent.
        Ann Oncol. 2010; 21: 397-402
        • Ardoino I.
        • Miceli R.
        • Berselli M.
        • et al.
        Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma.
        Cancer. 2010; 116: 2429-2436
        • Gronchi A.
        • Miceli R.
        • Shurell E.
        • et al.
        Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.
        J Clin Oncol. 2013; 31: 1649-1655
        • Stojadinovic A.
        • Yeh A.
        • Brennan M.F.
        Completely resected recurrent soft tissue sarcoma: primary anatomic site governs outcomes.
        J Am Coll Surg. 2002; 194: 436-447
        • MacNeill A.J.
        • Miceli R.
        • Strauss D.C.
        • et al.
        Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
        Cancer. 2017; 123: 1971-1978
        • van Houdt W.J.
        • Fiore M.
        • Barretta F.
        • et al.
        Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG.
        Cancer. 2020; 126: 4917-4925
        • Park J.O.
        • Qin L.X.
        • Prete F.P.
        • et al.
        Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.
        Ann Surg. 2009; 250: 977-982
        • Hamilton T.D.
        • Cannell A.J.
        • Kim M.
        • et al.
        Results of Resection for Recurrent or Residual Retroperitoneal Sarcoma After Failed Primary Treatment.
        Ann Surg Oncol. 2017; 24: 211-218
        • Trans-Atlantic R.P.S.W.G.
        Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group.
        Ann Surg Oncol. 2016; 23: 3531-3540
        • Glasbey J.C.
        • Bundred J.
        • Tyler R.
        • et al.
        The impact of postoperative radiological surveillance intensity on disease free and overall survival from primary retroperitoneal, abdominal and pelvic soft-tissue sarcoma.
        Eur J Surg Oncol. 2021; 47: 1771-1777
        • Raut C.P.
        • Callegaro D.
        • Miceli R.
        • et al.
        Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.
        Clin Cancer Res. 2019; 25: 2664-2671
        • Casali P.G.
        • Abecassis N.
        • Aro H.T.
        • et al.
        Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
        Ann Oncol. 2018; 29: iv51-iv67
        • Yahya Zaidi M.
        • Cardona K.
        Post-operative surveillance in soft tissue sarcoma: using tumor-specific recurrence patterns to direct approach.
        Chin Clin Oncol. 2018; 7: 45
        • Cipriano C.A.
        • Jang E.
        • Tyler W.
        Sarcoma Surveillance: A Review of Current Evidence and Guidelines.
        J Am Acad Orthop Surg. 2020; 28: 145-156
        • Gerrand C.H.
        • Billingham L.J.
        • Woll P.J.
        • et al.
        Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom.
        Sarcoma. 2007; : 34128
        • Richardson K.
        • Potter M.
        • Damron T.A.
        Image intensive soft tissue sarcoma surveillance uncovers pathology earlier than patient complaints but with frequent initially indeterminate lesions.
        J Surg Oncol. 2016; 113: 818-822
        • Goel A.
        • Christy M.E.
        • Virgo K.S.
        • et al.
        Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma.
        Int J Oncol. 2004; 25: 429-435
        • Fiore M.
        • Brunelli C.
        • Miceli R.
        • et al.
        A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: Clinical and Patient-Reported Outcomes 1 Year After Surgery.
        Ann Surg Oncol. 2021; 28: 3904-3916
        • Bauml J.M.
        • Troxel A.
        • Epperson C.N.
        • et al.
        Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety.
        Lung Cancer. 2016; 100: 110-113
        • Tyldesley-Marshall N.
        • Greenfield S.
        • Neilson S.J.
        • et al.
        The role of Magnetic Resonance Images (MRIs) in coping for patients with brain tumours and their parents: a qualitative study.
        BMC cancer. 2021; 21: 1013
        • Perhavec A.
        • Provenzano S.
        • Baia M.
        • et al.
        Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution.
        Ann Surg Oncol. 2021; 28: 1151-1157
        • Pasquali S.
        • Palassini E.
        • Stacchiotti S.
        • et al.
        Neoadjuvant treatment: a novel standard?.
        Curr Opin Oncol. 2017; 29: 253-259
        • Callegaro D.
        • Raut C.P.
        • Swallow C.J.
        • et al.
        Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program.
        Curr Opin Oncol. 2021; 33: 301-308